Furthermore, adding an ACE inhibitor to the β-cell line improved the hyperglycemia-induced decrease in Ins1 and Pdx-1 expression, and suppressed the expression of Ngn3, endocrine progenitor cell marker, and Oct4, stem-like cell marker [38]. The gene discussed is NEUROG3; the disease is Hyperglycemia.